164 related articles for article (PubMed ID: 22948778)
1. CYP1A1 Ile462Val polymorphism and cervical cancer: evidence from a meta-analysis.
Yang S; Jia C; Zhu H; Han S
Tumour Biol; 2012 Dec; 33(6):2265-72. PubMed ID: 22948778
[TBL] [Abstract][Full Text] [Related]
2. Quantitative synthesis of the association between the cytochrome P450 1A1 Ile462Val polymorphism and prostate cancer risk.
Han G; Ma Y; Liu P; Wei X; Zhang X; Zhu F
Tumour Biol; 2013 Jun; 34(3):1511-6. PubMed ID: 23381648
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between the CYP1A1 Ile462Val polymorphism and endometrial cancer risk: a meta-analysis.
Wang XW; Zhong TY; Xiong YH; Lin HB; Liu QY
Asian Pac J Cancer Prev; 2012; 13(8):3717-21. PubMed ID: 23098461
[TBL] [Abstract][Full Text] [Related]
4. The cytochrome P4501A1 gene polymorphisms and endometriosis: a meta-analysis.
Fan W; Huang Z; Xiao Z; Li S; Ma Q
J Assist Reprod Genet; 2016 Oct; 33(10):1373-1383. PubMed ID: 27525656
[TBL] [Abstract][Full Text] [Related]
5. Association between CYP1A1 Ile462Val variation and acute leukemia risk: meta-analyses including 2164 cases and 4160 controls.
Zhuo W; Zhang L; Zhu B; Qiu Z; Chen Z
PLoS One; 2012; 7(10):e46974. PubMed ID: 23056546
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 1A1 Ile462Val polymorphism and oral carcinoma risk: an updated meta-analysis including 1,515 cases and 2,233 controls.
Zhuo X; Zhao H; Chang A; Ye H; Zhou Y; Song Y; Tan Y
Tumour Biol; 2012 Dec; 33(6):2079-89. PubMed ID: 22847262
[TBL] [Abstract][Full Text] [Related]
7. CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis.
Jin JQ; Hu YY; Niu YM; Yang GL; Wu YY; Leng WD; Xia LY
World J Gastroenterol; 2011 Jan; 17(2):260-6. PubMed ID: 21246002
[TBL] [Abstract][Full Text] [Related]
8.
Wang LN; Wang F; Liu J; Jin YH; Fang C; Ren XQ
Front Physiol; 2017; 8():1081. PubMed ID: 29326607
[No Abstract] [Full Text] [Related]
9. Cytochrome P450 1A1 gene polymorphisms and cervical cancer risk: A systematic review and meta-analysis.
Ding B; Sun W; Han S; Cai Y; Ren M; Shen Y
Medicine (Baltimore); 2018 Mar; 97(13):e0210. PubMed ID: 29595663
[TBL] [Abstract][Full Text] [Related]
10. CYP1A1 Ile462Val polymorphism as a risk factor in cervical cancer development in the Polish population.
Roszak A; Lianeri M; Sowińska A; Jagodziński PP
Mol Diagn Ther; 2014 Aug; 18(4):445-50. PubMed ID: 24626963
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies.
Gong FF; Lu SS; Hu CY; Qian ZZ; Feng F; Wu YL; Yang HY; Sun YH
Tumour Biol; 2014 Oct; 35(10):10351-61. PubMed ID: 25048966
[TBL] [Abstract][Full Text] [Related]
12. The association of the CYP1A1 Ile462Val polymorphism with head and neck cancer risk: evidence based on a cumulative meta-analysis.
Wang Y; Yang H; Duan G; Wang H
Onco Targets Ther; 2016; 9():2927-34. PubMed ID: 27274286
[TBL] [Abstract][Full Text] [Related]
13. Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis.
Xia L; Gao J; Liu Y; Wu K
Tumour Biol; 2013 Feb; 34(1):223-30. PubMed ID: 23055196
[TBL] [Abstract][Full Text] [Related]
14. [Association of CYP1A1 Ile462Val polymorphisms with susceptibility to small cell lung cancer].
He B; Lin J; Cao L; Wang H; Rao J; Liu Y; Zhang Z
Wei Sheng Yan Jiu; 2014 May; 43(3):393-6, 418. PubMed ID: 24964616
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 1A1 gene polymorphisms and digestive tract cancer susceptibility: a meta-analysis.
Ren A; Qin T; Wang Q; Du H; Zhong D; Hua Y; Zhu L
J Cell Mol Med; 2016 Sep; 20(9):1620-31. PubMed ID: 27061602
[TBL] [Abstract][Full Text] [Related]
16. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis.
Zheng Y; Wang JJ; Sun L; Li HL
Mol Biol Rep; 2012 Apr; 39(4):3533-40. PubMed ID: 21710246
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and cervical cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP; Choussein S; Vlahos NF
Mol Biol Rep; 2012 Jun; 39(6):6647-54. PubMed ID: 22294106
[TBL] [Abstract][Full Text] [Related]
18. MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysis.
Wu B; Liu K; Huang H; Yuan J; Yuan W; Wang S; Chen T; Zhao H; Yin C
PLoS One; 2013; 8(12):e85166. PubMed ID: 24391993
[TBL] [Abstract][Full Text] [Related]
19. CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.
Ding G; Xu W; Liu H; Zhang M; Huang Q; Liao Z
Mol Biol Rep; 2013 May; 40(5):3483-91. PubMed ID: 23475304
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk.
Guo R; Guo X
Tumour Biol; 2012 Aug; 33(4):1125-32. PubMed ID: 22359202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
